About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5759821
Allelic
Composition
Trp53tm3Tyj/Trp53+
Tg(Wap-cre)11738Mam/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(Wap-cre)11738Mam mutation (3 available)
Trp53tm3Tyj mutation (3 available); any Trp53 mutation (232 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• 7 of 8 mice develop one or more tumors of the mammary gland after the first pregnancy
• mean latency time for spontaneous mammary tumor development is 19.7 +/- 8.6 weeks
• mammary tumors of both untreated and DMBA-treated mice are heterogeneous, including frequent adenocarcinomas, solid carcinomas, papillary carcinomas, and adenosquamous carcinomas, carcinosarcomas and sarcomas
• 67% of mammary tumors from untreated and DMBA-treated mice are estrogen receptor alpha-positive
• 40% of females exposed to DMBA for 6 weeks develop mammary tumors, with a mean latency time of 8.5 +/- 4.7 weeks
• females exposed to DMBA also develop lymphomas, ovary, lung, stomach, uterus and skin tumors
• some mice develop an additional lymphoma
• some mice develop an additional sarcoma in the abdomen
• some mice develop an additional tumor of the lung

mortality/aging
• premature death, with only 2 of 11 mice surviving past 78 weeks

endocrine/exocrine glands
• 7 of 8 mice develop one or more tumors of the mammary gland after the first pregnancy
• mean latency time for spontaneous mammary tumor development is 19.7 +/- 8.6 weeks
• mammary tumors of both untreated and DMBA-treated mice are heterogeneous, including frequent adenocarcinomas, solid carcinomas, papillary carcinomas, and adenosquamous carcinomas, carcinosarcomas and sarcomas
• 67% of mammary tumors from untreated and DMBA-treated mice are estrogen receptor alpha-positive

homeostasis/metabolism
• 40% of females exposed to DMBA for 6 weeks develop mammary tumors, with a mean latency time of 8.5 +/- 4.7 weeks
• females exposed to DMBA also develop lymphomas, ovary, lung, stomach, uterus and skin tumors

integument
• 7 of 8 mice develop one or more tumors of the mammary gland after the first pregnancy
• mean latency time for spontaneous mammary tumor development is 19.7 +/- 8.6 weeks
• mammary tumors of both untreated and DMBA-treated mice are heterogeneous, including frequent adenocarcinomas, solid carcinomas, papillary carcinomas, and adenosquamous carcinomas, carcinosarcomas and sarcomas
• 67% of mammary tumors from untreated and DMBA-treated mice are estrogen receptor alpha-positive

respiratory system
• some mice develop an additional tumor of the lung

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
breast cancer DOID:1612 OMIM:114480
J:101617


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
03/12/2024
MGI 6.23
The Jackson Laboratory